The MarketReader Minute
💊 Ionis Drops Despite Positive EU Recommendation, Gilead Faces Setback on Trodelvy, AbbVie Gains Canada Approval for EPKINLY | Biotech Sector Insights
The iShares Biotechnology ETF (IBB) has declined by 1.1% since Friday, coinciding with a broader market trend reflected in the Russell 2000 Index, which has dropped by nearly 1%.